Erratum to “Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?” ( Cardiovasc Revasc Med2010;11(2):91–7)




The correct spelling of the second author’s last name is Kakkar.


Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study
  2. The universal classification is an independent predictor of long-term outcomes in acute myocardial infarction
  3. Endovascular treatment of coronary steal
  4. Takotsubo cardiomyopathy in a patient with previously undiagnosed hypertrophic cardiomyopathy with obstruction

Stay updated, free articles. Join our Telegram channel
Tags:
Nov 16, 2017 | Posted by in CARDIOLOGY | Comments Off on Erratum to “Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?” ( Cardiovasc Revasc Med2010;11(2):91–7)

Full access? Get Clinical Tree
Get Clinical Tree app for offline access